Cipla to support Terra Carta, for sustainable future
Advertisement
Mumbai: Cipla Limited today announced that the company has pledged support to 'Terra Carta', a landmark charter that has been drawn up to put sustainability at the heart of the private sector. The charter is part of HRH The Prince of Wales' Sustainable Markets Initiative that was launched in Davos in 2020, with founding partners such as Bank of America, HSBC, BP and NatWest among others.
Since its launch in January 2021, the initiative has received support from 223 private sector organisations and 21 professional associations. Cipla is one of the five Indian companies and the only Indian pharmaceutical company to participate.
While continuing to achieve its own environmental, social and governance (ESG) goals, Cipla would also have the opportunity to drive ESG discourse within the sector and at a regional level. At the same time, the initative would allow participating organizations to cross-learn from one another.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.